Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 250: 121-8, 2013 Oct 10.
Article in English | MEDLINE | ID: mdl-23867765

ABSTRACT

Hyperprolinemia is an inherited disorder of proline metabolism and hyperprolinemic patients can present neurological manifestations, such as seizures, cognitive dysfunctions, and schizoaffective disorders. However, the mechanisms related to these symptoms are still unclear. In the present study, we evaluated the in vivo and in vitro effects of proline on acetylcholinesterase (AChE) activity and gene expression in the zebrafish brain. For the in vivo studies, animals were exposed at two proline concentrations (1.5 and 3.0mM) during 1h or 7 days (short- or long-term treatments, respectively). For the in vitro assays, different proline concentrations (ranging from 3.0 to 1000 µM) were tested. Long-term proline exposures significantly increased AChE activity for both treated groups when compared to the control (34% and 39%). Moreover, the proline-induced increase on AChE activity was completely reverted by acute administration of antipsychotic drugs (haloperidol and sulpiride), as well as the changes induced in ache expression. When assessed in vitro, proline did not promote significant changes in AChE activity. Altogether, these data indicate that the enzyme responsible for the control of acetylcholine levels might be altered after proline exposure in the adult zebrafish. These findings contribute for better understanding of the pathophysiology of hyperprolinemia and might reinforce the use of the zebrafish as a complementary vertebrate model for studying inborn errors of amino acid metabolism.


Subject(s)
Acetylcholinesterase/metabolism , Antipsychotic Agents/pharmacology , Brain Chemistry/drug effects , Brain Chemistry/genetics , Brain/drug effects , Gene Expression/drug effects , Proline/pharmacology , Zebrafish/physiology , Animals , Female , Haloperidol/pharmacology , In Vitro Techniques , Male , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Parasympathetic Nervous System/drug effects , Proline/antagonists & inhibitors , Real-Time Polymerase Chain Reaction , Sulpiride/pharmacology
2.
Neurotoxicol Teratol ; 33(6): 608-17, 2011.
Article in English | MEDLINE | ID: mdl-21907791

ABSTRACT

Recent advances in neurobiology have emphasized the study of brain structure and function and its association with numerous pathological and toxicological events. Neurotransmitters are substances that relay, amplify, and modulate electrical signals between neurons and other cells. Neurotransmitter signaling mediates rapid intercellular communication by interacting with cell surface receptors, activating second messenger systems and regulating the activity of ion channels. Changes in the functional balance of neurotransmitters have been implicated in the failure of central nervous system function. In addition, abnormalities in neurotransmitter production or functioning can be induced by several toxicological compounds, many of which are found in the environment. The zebrafish has been increasingly used as an animal model for biomedical research, primarily due to its genetic tractability and ease of maintenance. These features make this species a versatile tool for pre-clinical drug discovery and toxicological investigations. Here, we present a review regarding the role of different excitatory and inhibitory neurotransmitter systems in zebrafish, such as dopaminergic, serotoninergic, cholinergic, purinergic, histaminergic, nitrergic, glutamatergic, glycinergic, and GABAergic systems, and emphasizing their features as pharmacological and toxicological targets. The increase in the global knowledge of neurotransmitter systems in zebrafish and the elucidation of their pharmacological and toxicological aspects may lead to new strategies and appropriate research priorities to offer insights for biomedical and environmental research.


Subject(s)
Central Nervous System/drug effects , Models, Animal , Neurotransmitter Agents/metabolism , Pharmacology/methods , Toxicology/methods , Zebrafish/metabolism , Animals , Behavior, Animal/drug effects , Central Nervous System/metabolism , Synaptic Transmission/drug effects
3.
Neurotoxicology ; 32(1): 116-22, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21074552

ABSTRACT

Pollution is a world problem with immeasurable consequences. Heavy metal compounds are frequently found as components of anthropogenic pollution. Here we evaluated the effects of the treatment with cadmium acetate, lead acetate, mercury chloride, and zinc chloride in acetylcholinesterase activity and gene expression pattern, as well as the effects of these treatments in antioxidant competence in the brain of an aquatic and well-established organism for toxicological analysis, zebrafish (Danio rerio, Cyprinidae). Mercury chloride and lead acetate promoted a significant decrease in acetylcholinesterase activity whereas they did not alter the gene expression pattern. In addition, the antioxidant competence was decreased after exposure to mercury chloride. The data presented here allowed us to hypothesize a signal transmission impairment, through alterations in cholinergic transmission, and also in the antioxidant competence of zebrafish brain tissue as some of the several effects elicited by these pollutants.


Subject(s)
Acetylcholinesterase/metabolism , Antioxidants/metabolism , Brain/drug effects , Brain/enzymology , Environmental Exposure/adverse effects , Metals, Heavy/toxicity , Animals , Brain/metabolism , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/toxicity , Enzyme Activation/drug effects , Enzyme Activation/physiology , Female , Male , Metals, Heavy/administration & dosage , Zebrafish
4.
Neuroscience ; 171(3): 683-92, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-20884336

ABSTRACT

Ethanol (EtOH) is a drug widely consumed throughout the world that promotes several neurochemical disorders. Its deleterious effects are generally associated with modifications in oxidative stress parameters, signaling transduction pathways, and neurotransmitter systems, leading to distinct behavioral changes. Taurine (2-aminoethanesulfonic acid) is a ß-amino acid not incorporated into proteins found in mM range in the central nervous system (CNS). The actions of taurine as an inhibitory neurotransmitter, neuromodulator, and antioxidant make it attractive for studying a potential protective role against EtOH-mediated neurotoxicity. In this study, we investigated whether acute taurine cotreatment or pretreatment (1 h) prevent EtOH-induced changes in acetylcholinesterase (AChE) activity and in oxidative stress parameters in zebrafish brain. The results showed that EtOH exposure (1% in volume) during 1 h increased AChE activity, whereas the cotreatment with 400 mg·L(-1) taurine prevented this enhancement. A similar protective effect of 150 and 400 mg·L(-1) taurine was also observed when the animals were pretreated with this amino acid. Taurine treatments also prevented the alterations promoted in superoxide dismutase and catalase activities by EtOH, suggesting a modulatory role in enzymatic antioxidant defenses. The pretreatment with 150 and 400 mg·L(-1) taurine significantly increased the sulfydryl levels as compared to control and EtOH groups. Moreover, 150 and 400 mg·L(-1) taurine significantly decreased thiobarbituric acid reactive species (TBARS) levels, but the cotreatment with EtOH plus 400 mg·L(-1) taurine did not prevent the EtOH-induced lipoperoxidation. In contrast, the pretreatment with 150 and 400 mg·L(-1) taurine prevented the TBARS increase besides decreased the basal levels of lipid peroxides. Altogether, our data showed for the first time that EtOH induced oxidative stress in adult zebrafish brain and reinforce the idea that this vertebrate is an attractive alternative model to evaluate the beneficial effect of taurine against acute EtOH exposure.


Subject(s)
Acetylcholinesterase/drug effects , Alcohol-Induced Disorders, Nervous System/drug therapy , Brain/drug effects , Cholinesterase Inhibitors/pharmacology , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Taurine/pharmacology , Acetylcholinesterase/metabolism , Alcohol-Induced Disorders, Nervous System/enzymology , Alcohol-Induced Disorders, Nervous System/metabolism , Animals , Brain/enzymology , Brain/metabolism , Cholinesterase Inhibitors/metabolism , Disease Models, Animal , Female , Male , Neuroprotective Agents/metabolism , Oxidative Stress/physiology , Species Specificity , Taurine/metabolism , Zebrafish
SELECTION OF CITATIONS
SEARCH DETAIL
...